Today's Rundown Former GSK cancer scientist admits attempt to steal trade secrets CRISPR Therapeutics, Vertex start first company-backed human CRISPR trial Job cuts among ‘tangible changes' in Bayer’s R&D review: Reuters Abivax posts ulcerative colitis data, commits to phase 2b BioCryst says oral drug works for HAE attacks Redmile, GV power exosome specialist Evox to £36M round Sanofi diabetes VP jumps to NYC metabolic disease startup Applied Therapeutics Featured Story | | | Tuesday, September 4, 2018 A scientist who worked at GlaxoSmithKline’s R&D unit in Philadelphia has pleaded guilty to attempting to steal confidential research and funnel it to conspirators in China. |
|
|
| This week's sponsor is Trianni. | | | |
Top Stories Friday, August 31, 2018 CRISPR Therapeutics and Vertex Pharmaceuticals are the first companies to sponsor a human trial of CRISPR gene editing. The trial will take place at a single site in Germany and will test a gene therapy in patients with beta thalassemia. Tuesday, September 4, 2018 A management review at Bayer could result in job cuts and outsourcing the company’s drug-testing services, according to Reuters. The new report comes just months after a German business weekly said that up to 1,000 positions could be on the chopping block. Tuesday, September 4, 2018 Abivax has posted data from a phase 2a trial in patients with moderate-to-severe ulcerative colitis that are refractory. The trial linked ABX464 to improvements in mucosal healing and performance on a symptom scale, leading Abivax to commit to a phase 2b. Tuesday, September 4, 2018 BioCryst says its BCX7353 drug was effective in treating acute hereditary angioedema (HAE) attacks in a midstage trial, setting up a possible registration study as an alternative to current injectable or intravenous therapies. Tuesday, September 4, 2018 Evox Therapeutics has raised £35.5 million ($45.4 million) to support its pipeline of exosome-based drugs. The series B, which attracted the support of GV, sets Evox up to take rare disease candidates into the clinic. Tuesday, September 4, 2018 Sanofi VP and Senior Medical Officer Riccardo Perfetti, M.D., Ph.D., has jumped to the metabolic disease startup Applied Therapeutics to become its chief medical officer as it moves into first-in-human trials. Resources Sponsored by: Patheon, part of Thermo Fisher Scientific When developing a parenteral, pharmaceutical scientists are faced with a variety of choices – choices that can be conflicting or present differing advantages. Sponsored by: Baxter Baxter BioPharma Solutions’ whitepaper offers a method to address the challenges of tech transfer for lyophilized products from lab-scale to commercial-scale. Sponsored by: Blue Matter A whitepaper outlining the key commercial challenges facing rare disease products, and how biopharmaceutical companies can overcome them. Sponsored by: AWS and Tableau Inova is using the capabilities of Tableau on AWS to identify biomarkers for personalized treatment intended to improve health outcomes for children. Sponsored by: Catalent In this case study, an unknown leachable species was detected by GC-MS analysis of an alkaline drug product (pH approximately 10.5) that was packaged in a novel self- contained plastic Blow Fill Seal (BFS) vial. Sponsored by: AWS and Reltio Reltio and IQVIA provide holistic data management solutions for traditional pharma, emerging biotech, and consumer health companies, on AWS. Presented by: AWS and Druva Life Sciences organizations are embracing cloud-based Master Data Management (MDM) to modernize the organization of critical data. Sponsored by: Catalent Catalent provides world class stability services to ease your critical path to success. Sponsored by: Health Strategies Group The window of market exclusivity continues to narrow dramatically in the global marketplace. Given this demanding environment, your global market access team faces increasing urgency to get the value proposition right at the time of launch. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. Sponsored by: PharmaCord When was the last time your patient support program perfectly aligned with the patient journey, solving all the critical gaps in positioning your brand for success? Follow the 3-D approach to your solution design, and you will achieve a better outcome for your patients. Sponsored by: Catalent Develop a basic understanding of principles and concepts of bioavailability of oral drugs. Drug Approval, Manufacturing Quality & Regulation 2018 | Online RESI HealthTech Week September 5-7, 2018 | Boston, MA 2018 Latin America Healthcare Compliance Certification Program September 24-27, 2018 | Sao Paulo, Brazil Drug Development Immersion September 26-27, 2018 | West Windsor, NJ FierceBiotech 3rd Drug Development Forum October 1–3, 2018 | Hilton Boston Logan Airport Hotel | Boston, MA Compliance Certification Program at Seton Hall Law October 8-11, 2018 | Newark, NJ BioImmersion: Biotech for the Non-Scientist October 16-18, 2018 | Chicago, IL Fierce Innovation Awards: Life Sciences Edition 2018 FierceBiotech Executive Summit: London October 30, 2018 | Royal Society of Medicine Understanding Commercialization Within Biopharma Nov 7-8, 2018 | Boston, MA Drug Development Boot Camp® 2018 – Register Now! November 14-15, 2018 | Boston, MA | Register now and start your pre-Boot Camp preparation Drug Development Immersion December 5-6, 2018 | San Diego, CA Understanding Drug Pricing and Reimbursement December 12, 2018 | Boston, MA | 